Abstract:Diabetes is a global public health disease projected to affect 642 million adults by 2040, with about 75% residing in low- and middle-income countries. Diabetic retinopathy (DR) affects 1 in 3 people with diabetes and remains the leading cause of blindness in working-aged adults. There are 3 broad strategic imperatives to prevent blindness caused by DR. Primary prevention requires preventing or delaying the onset of DR in those with diabetes by systems-level lifestyle modifications such as increasing physical activity or dietary modifications, pharmacological interventions for glycaemic and blood pressure control, and systematic screening for the onset of DR. Secondary prevention requires preventing the progression of DR in patients with DR by continuing systemic risk factor control, regular screening to monitor for the progression of mild DR to vision-threatening stages, and the development and implementation of evidence-based guidelines for managing DR. In this aspect, telemedicine-based DR screening incorporating artificial intelligence technology has the potential to facilitate more widespread and cost-effective screening, particularly in low- and middle-income countries. Tertiary prevention of DR blindness has been the main focus of the clinical ophthalmology community, classically based on laser photocoagulation treatment and ocular surgery but with an increasing use of anti-vascular endothelial growth factor (anti-VEGF) for vision-threatening DR. Evidence from serial epidemiological studies shows blindness due to DR has declined in high-income countries (e.g., the USA and UK) due to coordinated public health education efforts, increased awareness, early detection by DR screening, sustained systemic risk factor control, and the availability of effective tertiary level treatment. However, the progress made in reducing DR blindness in high-income countries may be overwhelmed by the increasing numbers of patients with diabetes and DR in low- and middle-income countries (e.g., China, India, Indonesia, etc.). Thus, to tackle DR at a global level, a paradigm shift in strategic focus from tertiary towards secondary and primary prevention measures with a multi-pronged whole-of-society approach at regional and national levels is urgently needed.Ophthalmologica

[Importance of Full-Cycle Management for Diabetic Retinopathy].

[Active response to high momentum of diabetic retinopathy with the strategy of combined treatment and prevention].

[Emphasizing the Early Prevention and Treatment for Diabetic Retinopathy].

Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence

Prevention and treatment of diabetic retinopathy: progress, challenges and future prospects

Current research and future strategies for the management of vision-threatening diabetic retinopathy

Diabetic retinopathy in China: Epidemiology, screening and treatment trends—A review

Research Progress on Artificial Intelligence in Diabetic Retinopathy

Application of Digital Imaging of Telemedicine on Diabetic Retinopathy Screening

Comprehensive Guidelines and Best Practices for Implementing Effective Diabetic Retinopathy Screening Programs to Mitigate Global Vision Loss

Recent advances in the treatment and delivery system of diabetic retinopathy

Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema

Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy

Advancement in Understanding Diabetic Retinopathy: A Comprehensive Review

Application Research of Artificial Intelligence Screening System for Diabetic Retinopathy

Early diagnostic methods for diabetic retinopathy

Diagnosis of Diabetic Retinopathy Using Deep Neural Networks

Automatic Diabetic Retinopathy Diagnosis Using Adjustable Ophthalmoscope and Multi-Scale Line Operator

A Deep Learning System for Predicting Time to Progression of Diabetic Retinopathy

A Survey on Intelligent Screening for Diabetic Retinopathy.